Customer Guest RE-KYC
please type the captcha code.
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Customer Guest
Login | Register
Login | Register|Forgot password?
Transcript of Q1FY26 Earning Conference Callmore...
Aarti Drugs Limited has informed the Exchange about Transcriptmore...
Recording of earning conference call for the quarter ended June 30 2025more...
Aarti Drugs Limited has informed the Exchange about Link of Recordingmore...
Aarti Drugs Limited has informed the Exchange about Copy of Newspaper Publicationmore...
Aarti Drugs Limited has informed the Exchange about Investor Presentationmore...
Q1FY26 Investor Presentationmore...
As of June 2025 55.23% is owned by Indian Promoters and 44.78% by Public. Institutional holds 12.20% (Insurance Companies 0.08%) and Non-Ins...more...
Aarti Drugs Limited has informed the Exchange regarding a press release dated July 18 2025 titled Q1 & FY26 Business & Financial Performance .more...
Press Release on financial results for the quarter ended June 30 2025more...
AARTI DRUGS LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agentmore...
Appointment of Secretarial Auditormore...
Aarti Drugs Limited has informed the Exchange regarding Appointment of Mr Mehta & Meh as Other of the company w.e.f. July 18 2025.more...
The company reported standalone net profit of Rs 48.64 crore for the quarter ended June 30 2025 as compared to Rs 26.91 crore in the same period last...more...
Audited Standalone and Consolidated Financial Results for the Quarter ended June 30 2025 and Outcome of the Meeting of the Board of Director...more...
Aarti Drugs Limited has informed the Exchange regarding Board meeting held on July 18 2025.more...
Aarti Drugs Limited has submitted to the Exchange the financial results for the period ended Jun 30 2025.more...
Financial Results for the quarter ended June 30 2025more...
Reply to the clarification sought with respect to increase in the volume of security across the exchange.more...
Enter Stock
BOARD MEETINGS Company Name : Andhra Sugars Date : 09-08-2025